Stock ALZ ALZINOVA AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Alzinova AB

Equities

ALZ

SE0007413455

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 09:46:21 2024-04-23 am EDT 		5-day change 1st Jan Change
1.834 SEK -2.03% Intraday chart for Alzinova AB +2.00% -39.57%
Apr. 11 Alzinova AB Completes In-Depth Analysis of Data from Part A of Alzinova's Phase 1B Study with the Vaccine Candidate ALZ-101 CI
Apr. 04 Alzinova AB Announces All Patients in the Extension Part of the Phase 1B Study Have Received Their Last Dose of ALZ-101 CI

Business Summary

Alzinova AB is a Sweden-based company, which is primarily involved in the biotechnology industry. The Company is engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease. The Company focuses on development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody (ALZ-201). Both products are specifically directed towards the form of oligomeric Aβ that damages brain synapses.

Number of employees: 4

Managers

Managers TitleAgeSince
Kristina Torfgård CEO
 Chief Executive Officer 61 19-12-15
Anders Sandberg FOU
 Founder 52 11-08-16
Kirsten Harting CTO
 Chief Tech/Sci/R&D Officer - 23-08-13
Sebastian Hansson PRN
 Corporate Officer/Principal - 22-12-31
Stefan Pierrou PRN
 Corporate Officer/Principal 59 20-12-31
Margareth Jorvid LAW
 General Counsel 63 21-12-31

Members of the board

Members of the board TitleAgeSince
Anders Waas BRD
 Director/Board Member 67 17-12-31
Per-Göran Gillberg BRD
 Director/Board Member 68 19-12-31
Julian Aleksov CHM
 Chairman 59 22-12-31
Lena Birgitta Degling Wikingsson BRD
 Director/Board Member 61 19-12-31
Clas Malmeström BRD
 Director/Board Member 59 15-08-31
Karl Blom BRD
 Director/Board Member 55 20-12-31
Carol Routledge BRD
 Director/Board Member - 17-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,531,265 28,168,822 ( 63.26 %) 0 63.26 %

Company contact information

Alzinova AB

Pepparedsleden 1

431 83, Mölndal

+46 7 08 46 79 75

http://www.alzinova.com
address Alzinova AB(ALZ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ALZINOVA AB Stock Alzinova AB
-38.25% 7.64M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.02% 42.11B
LONZA GROUP AG Stock Lonza Group AG
+48.71% 40.08B
MODERNA, INC. Stock Moderna, Inc.
+5.04% 40B
CELLTRION, INC. Stock Celltrion, Inc.
-11.32% 26.87B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.25% 24.58B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.83% 18.44B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.62% 11.94B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+22.75% 11.66B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.44% 11.01B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALZ Stock
  4. Company Alzinova AB